First hantavirus, now Ebola: What two outbreaks reveal about global preparedness
First hantavirus, now Ebola: What two outbreaks reveal about global preparedness
News Search
Search results for Statnews
Search Results
115 results found
STAT Plus: Takeda will pay $13.6 million to settle allegations it paid kickbacks to doctors
STAT Plus: Takeda will pay $13.6 million to settle allegations it paid kickbacks to doctors
European Union inks a draft deal to boost local production of medicines and avoid shortages
The deal comes amid a backdrop of geopolitical tensions prompted by the Trump administration's efforts to lower the cost of prescription drugs in the U.S.
Males who discuss suicide seek help less often than females, report finds
Men account for 80% of U.S. suicides but 20% of traffic to mental health crisis line. New report says males see seeking help as a weakness.
Hims takes a $33 million hit from GLP-1 ‘pivot’
In this edition of STAT Health Tech: A closer look at Hims earnings, Omada's PBM strategy, and the uphill battle faced by new sepsis prediction algorithms.
STAT examines America’s deadliest drug
D.C. Diagnosis newsletter: A scramble for Medicaid work requirement exemptions and a look at an epidemic hiding in plain sight.
Capsida says it still doesn’t know what caused gene therapy death
Capsida Biotherapeutics discloses fatal gene therapy targeted ADAM-15, a receptor others avoided, says it still doesn't know precise cause of death.
Pharma and biotech leaders are destroying their own industry
With their focus on China, American biotech leaders are prioritizing short-term profits over the long-term stability of the industry.
PCOS’s new name is PMOS, a small letter change that required a big scientific process
After hearing from 22,000 people over 11 years, polycystic ovary syndrome (PCOS) was renamed polyendocrine metabolic ovarian syndrome (PMOS).
Colombia wins a key court ruling over a compulsory license issued for an HIV medicine
At issue is dolutegravir, which is used in combination with other antiretroviral drugs to treat HIV and AIDS in adults and children
Medicare’s miss on Alzheimer’s drug spending
Few Medicare beneficiaries are getting costly Alzheimer's drugs, providers and insurers lobby on surprise billing, and more from STAT's Health Care Inc.
Trump pivots on kratom derivative 7-OH, floating approval for some forms
The president appears to favor giving some forms of kratom, a natural opioid, approval, despite recent FDA warnings about such products.
No FDA permission, no problem: New flavored vape policy worries experts
FDA announced new enforcement guidance, allowing some unauthorized vapes to stay on the market while applications are processed. Experts foresee problems.
What addiction medicine can teach us about depending on AI
When people hear the word “addiction,” they often assume it implies catastrophe. But it starts with the gradual shift from optional use to psychological reliance.
Trump reportedly plans to fire FDA Commissioner Makary
Makary's ambitious plans were often derailed by personnel dramas, deep staff cuts, leadership departures, and controversy over politics interfering with science.
Fraudulent citations, blamed on AI hallucinations, are becoming more common in research papers
Frequency of false references rose six-fold from 2023-2025, says Lancet study. Publishers turn to integrity tools to fight AI slop.
Roche to buy PathAI for $750 million
Swiss pharma company Roche signed a deal to acquire PathAI to speed up its use of artificial intelligence to help pathologists diagnose diseases.
Former FDA leaders, pharma speak out on mifepristone
States can regulate abortion, but the FDA regulates drugs. That conflict is drawing friend of the court briefs from former FDA execs and pharma companies.
I’m fighting misinformation online. False hantavirus claims follow a now-familiar playbook
Hantavirus outbreak is serious but limited. Online, it's another story. Katrine Wallace, a medical misinformation expert, explains why ivermectin is back.
Medicare’s new RAPID pathway is a breakthrough for adults. Children are still waiting
Medicare's new RAPID pathway is a breakthrough for adults. Children are still waiting.
Key takeaways from WHO briefing on hantavirus cruise ship outbreak
No illnesses reported aboard the Hondius, currently en route to the Canary Islands. WHO is coordinating how to get passengers off the ship and safely home.
Color me skeptical: Drinking gold is not an ALS cure
In this week's edition of "Adam's Biotech Scorecard," he dares to raise questions about a liquid gold oral supplement for ALS.
Science is becoming less disruptive. Is an aging workforce to blame?
Researchers find younger scientists drive disruptive discoveries while older peers play it safer, suggesting aging workforce slows innovation.
Seaport’s IPO adventure, obesity pill battles, and Makary’s troubles
Also on the podcast this week, a chat with Seaport Therapeutics CEO Daphne Zohar, fresh off the biotech’s successful IPO.